|
We asked 60 industry leaders,  Which of the following has the most negative impact
on biopharmaceutical drug development?
| M&As |
55% |
Counterfeit drugs |
18% |
| Regulations |
27% |
|
|
 |
|
|
|
|
|
12 Aug, 2014
|
|
|
Pharm Exec’s Emerging Pharma Leaders 2014
This year's class of 15 young executives is deeply of the moment, with wide-ranging therapeutic, business, and operational expertise — all binded by an underlying commitment to the patient. Read more |
Google Glass — A User’s Guide in Healthcare
In the health sector, Google Glass is envisioned to provide unique benefits for communicating medical information to healthcare professionals. The big question for sales professionals is whether this will work well in practice. Sean Turbeville, David A. Wells and Charles Wolfus purchased three Google Glass units to test them in a real-world setting... Read more
|
Apple or Big Pharma: Who Will Lead in the Wearable Healthcare Technology Space?
Apple’s iWatch may be yet to happen, but as Peter Houston explains, there’s a lot to be excited about in the burgeoning wearable healthcare technology space ... Read more
|
Unified Communications: A Fitter Future for Pharma
If firms want to maintain profitability in an increasingly competitive, highly regulated and culturally diverse global landscape, they need to work faster and more efficiently. To this end, it’s critical they improve the way they communicate and collaborate, both within and outside their company walls, writes Richard Freeman.... Read more
|
Good Customer Experience (CX) in Healthcare
Thanks to social media, a good or bad customer experience (CX) can go viral and make or break a business. But does this CX argument stand true in health? Kate Eversole talks to Michelle Hawkins of Virgin Cares on how CX is being optimized for the healthcare environment.... Read more
|
|
|
|
|
